Keywords: unimed, antiparasitic, agent, ntz, phase, iii, news

Unimed's antiparasitic agent NTZ: Phase III news

Article | 15 January 1996

Print This

- A Phase III trial of Unimed Pharmaceuticals' antiparasitic agent NTZ (nitazoxanide) has begun in Mexico. The study will assess the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in